AKDITAL S.A |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 674 MAD | -.--% |
|
+0.60% | +35.89% |
| 2023 | Akdital S.A Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Akdital S.A(CBSE:AKT) added to S&P Pan Arab Composite | CI |
| Sales 2023 * | 1.92B 193M | Sales 2024 * | 2.44B 245M | Capitalization | 8.54B 858M |
|---|---|---|---|---|---|
| Net income 2023 * | 166M 16.68M | Net income 2024 * | 236M 23.71M | EV / Sales 2023 * | 4.75 x |
| Net Debt 2023 * | 592M 59.49M | Net Debt 2024 * | 1.08B 108M | EV / Sales 2024 * | 3.95 x |
| P/E ratio 2023 * |
52.2
x | P/E ratio 2024 * |
35.9
x | Employees | 2,900 |
| Yield 2023 * |
0.89% | Yield 2024 * |
1.2% | Free-Float | 31.59% |
More Fundamentals
* Assessed data
More news
| 1 week | +0.60% | ||
| 1 month | -6.41% | ||
| 3 months | -3.44% | ||
| 6 months | +36.85% | ||
| Current year | +35.89% |
1 week
669.00
682.00
1 month
664.90730.00
Current year
495.00760.00
1 year
315.00760.00
3 years
270.00760.00
5 years
270.00760.00
10 years
270.00760.00
| Managers | Title | Age | Since |
|---|---|---|---|
Rochdi Talib
CEO | Chief Executive Officer | - | 16-08-18 |
Imad El Baggar
CTO | Chief Tech/Sci/R&D Officer | - | 17-11-30 |
| Chief Tech/Sci/R&D Officer | - | 18-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 22-11-15 | |
Saâd Bendidi
BRD | Director/Board Member | 65 | 20-03-23 |
Hatim Ben Ahmed
BRD | Director/Board Member | - | 20-03-23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 674 | -.--% | 5,359 |
| 24-05-30 | 674 | -0.15% | 3,939 |
| 24-05-29 | 675 | +0.75% | 4,771 |
| 24-05-28 | 670 | -0.30% | 3,009 |
| 24-05-27 | 672 | +0.30% | 1,461 |
End-of-day quote Casablanca S.E., May 30, 2024
More quotes
Akdital is specialized in owning and operating private healthcare institutions, and clinics. The company primarily offers medical, surgical, oncological and pediatric care services.
At the end of 2021, Akdital operated 15 healthcare institutions (1,602 beds) located in Morocco.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
674
MAD
Average target price
448.5
MAD
Spread / Average Target
-33.46%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +35.89% | 858M | |
| -23.39% | 15.56B | |
| -2.70% | 11.65B | |
| +2.65% | 11.58B | |
| +2.37% | 10.06B | |
| -10.45% | 7.16B | |
| +8.05% | 6.85B | |
| -4.29% | 5.71B | |
| +13.33% | 4.3B | |
| -3.96% | 4.3B |
- Stock Market
- Equities
- AKT Stock
